A Pioneer Globally to Detect Amyloid-β(Aβ) by Urine

MORE +

湖南乾康科技有限公司

MORE +

scroll down

One Step Dementia Risk Test Kit

Urine-based amyloid-β biomarker testing for risk of Alzheimer's Disease

Sensivity 75.7%，Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

Learn More

One Step Dementia Risk Test Kit

Urine-based amyloid-β biomarker testing for risk of Alzheimer's Disease

Sensivity 75.7%，Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

Learn More

One Step Dementia Risk Test Kit

Urine-based amyloid-β biomarker testing for risk of Alzheimer's Disease

Sensivity 75.7%，Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

Learn More

One Step Dementia Risk Test Kit

Sensivity 75.7%，Specificity 91.03%

First Globally

Clinically approved

Accurate

Non-invasive

Fast: 10 Mins have the result

View Details

International scientific research team

Many researchers, including Professor Baijun Gu Qankorey Life Science R&D Center, Chief Scientist of Qankorey Technology, and Colin Masters, Chief Scientific Advisor of Qankorey Technology.

→

Baijun Gu Qankorey Life Science R&D Center

Qankorey Life International R & D Center

Including the Qankorey Life Science (Changsha) R&D Center and Qankorey Life Science (Melbourne) Research Center, we provide comprehensive solutions for the prevention, screening, diagnosis, and treatment of Alzheimer's disease.

→

Industry-university-research cooperation

We have established cooperation with AIBL and Florey research institutes abroad, as well as with various research institutes and hospitals such as Huashan Hospital and Ruijin Hospital of Fudan University in China.

→

Qualifications and Patents

Undertaking more than ten major special projects of the Ministry of Science and Technology and provincial and municipal governments, possessing more than 160 intellectual property rights such as patents and software copyrights.

→

R&D and Manufacturing

A biotechnology enterprise that focuses on the research of key technologies for Alzheimer's disease (AD), a global medical challenge. It provides full industry chain services in research and development, production, and sales, achieving full process management of Alzheimer's disease.

Globalization Development

Speed up the internationalization strategy and create a new pattern in the AD market.

The business has spread across Asia, Europe, North America, Oceania, Africa and other places. It is continuously enhancing brand influence and steadily advancing the international marketing strategy.

Join us

News And Events

2024-10-10

Waiting To See You At Medica Germany 2024

2024-09-21

31st World Alzheimer's Day: Let's act now to light up memory！

2024-09-20

Warmly Welcome Nobel Prize Nominee Professor Colin L Masters to visit Qankorey Life Science R&D Center

Enterprise dynamics

2024-10-10

Misuse operation

Hunan Qankorey Biotechnology Co.,Ltd.

Domestic business consulting Tel:+86-731-85714218

E-mail:yingxiao@qankorey.com

Internation Marketing Tel:+86-18874232226

E-mail:lisa@qankorey.com

Company address: 12F, Building 15, 188 Middle Huanbao Road, Yuhua District, Changsha, Hunan , 410116, China

Production Address: 4/F, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha,Hunan China,410007

Public Number

Small program

Jingdong

Taobao

This site supports ipv4 ipv6.

Business License

SEO